Guerbet Logo

Guerbet

Offers medical imaging solutions, from contrast agents to AI, for healthcare professionals.

GBT | PA

Overview

Corporate Details

ISIN(s):
FR0000032526 (+3 more)
LEI:
969500WV1U1WQ059L135
Country:
France
Address:
15 RUE DES VANESSES, 93420 VILLEPINTE
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Guerbet is a global leader in medical imaging, specializing in diagnostic and interventional imaging solutions for healthcare professionals. Since its establishment in 1926, the company has developed and commercialized a comprehensive portfolio that includes contrast agents, medical devices, delivery systems, and digital and AI-powered solutions. Guerbet's products are utilized to improve the diagnosis and treatment of major disease areas such as cancer, as well as cardiovascular, inflammatory, and neurodegenerative diseases. The company focuses on providing innovative and safe solutions to enhance patient care and support radiology professionals worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 17:45
Earnings Release
Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on…
English 524.6 KB
2025-09-24 17:45
Earnings Release
Guerbet : Résultats semestriels 2025 : Chiffre d’affaires du 1er semestre : 387…
French 496.3 KB
2025-09-22 17:45
Board/Management Information
Guerbet : Evolution de la Direction Générale
French 134.4 KB
2025-09-22 17:45
Board/Management Information
Guerbet : Change in General Management
English 113.8 KB
2025-09-18 17:45
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
French 159.1 KB
2025-09-15 17:50
Earnings Release
Guerbet : Ajustement des objectifs financiers annuels 2025
French 209.3 KB
2025-09-15 17:50
Earnings Release
Guerbet : Adjustment of 2025 full-year financial targets
English 186.1 KB
2025-08-13 17:45
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
French 158.8 KB
2025-07-25 17:45
Regulatory News Service
GUERBET : Descriptif du programme de rachat d’actions autorisé par l’Assemblée …
French 170.5 KB
2025-07-09 17:45
Regulatory News Service
GUERBET : Bilan semestriel du contrat de liquidité
French 116.1 KB
2025-07-08 17:30
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
French 99.1 KB
2025-06-18 17:30
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
French 98.5 KB
2025-05-26 08:42
Post-Annual General Meeting Information
Guerbet : Evolution de la composition du Conseil d'administration de Guerbet.
French 250.9 KB
2025-05-26 08:42
Board/Management Information
Guerbet : Changes in the composition of the Guerbet board of directors.
English 164.7 KB
2025-05-16 17:30
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
French 96.3 KB

Automate Your Workflow. Get a real-time feed of all Guerbet filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Guerbet via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-08-19 N/A Other Buy 142 4,989.31 EUR
2024-08-15 N/A Other Buy 195 6,678.75 EUR
2024-08-12 N/A Other Buy 1,000 34,350.00 EUR
2024-04-18 N/A Other Sell 550 17,699.00 EUR
2023-11-30 N/A Other Sell 700 12,684.00 EUR
2023-11-03 N/A Other Buy 1 17.92 EUR
2023-10-30 N/A Other Buy 1,000 17,000.00 EUR
2023-10-25 N/A Other Buy 1,000 16,800.00 EUR
2023-10-24 N/A Other Buy 1,000 16,460.90 EUR
2023-05-04 N/A Other Buy 300 4,938.00 EUR

Peer Companies

Company Country Ticker View
3-D Matrix,Ltd. Logo
Develops peptide-based medical devices for surgical bleeding control and wound healing.
Japan 7777
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France ABLD
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom AMS
Affluent Medical Logo
Developing minimally invasive, restorative implants for structural heart disease and urology.
France AFME
AIOBIO Co., Ltd. Logo
Develops AI biofluorescence dental tools for early detection of caries and plaque.
South Korea 447690
Airway Medix S.A. Logo
Develops single-use devices for mechanically ventilated patients in ICUs and anesthesiology.
Poland AWM
Alcon AG Logo
Global leader in eye care, offering surgical equipment, contact lenses, and ocular health products.
Switzerland ALC
Aligned Genetics, Inc. Logo
Develops advanced equipment for cell imaging and diagnostics for research & medicine.
South Korea 238120
Allmed Solutions Ltd. Logo
Develops, manufactures, and markets minimally invasive medical devices and solutions globally.
Israel ALMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.